ImmuCell Corporation (ICCC)

NASDAQ: ICCC · IEX Real-Time Price · USD
8.02
-0.18 (-2.19%)
Aug 19, 2022 4:30 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012
Revenue
19.2415.3413.7210.9910.439.5410.237.66.015.39
Revenue Growth (YoY)
25.42%11.80%24.91%5.32%9.29%-6.69%34.64%26.46%11.45%5.46%
Cost of Revenue
10.598.486.985.795.214.123.983.152.952.34
Gross Profit
8.666.866.745.195.225.426.254.453.063.05
Selling, General & Admin
4.233.894.013.823.423.292.892.481.931.89
Research & Development
4.174.353.693.522.051.241.242.181.150.92
Other Operating Expenses
000-0.7000000
Operating Expenses
8.48.247.696.645.464.534.134.663.082.81
Operating Income
0.26-1.38-0.95-1.45-0.240.892.12-0.21-0.020.25
Other Expense / Income
0.33-0.350.310.410.20.130.060.05-0.220.05
Pretax Income
-0.07-1.03-1.27-1.86-0.440.762.06-0.260.210.19
Income Tax
0.01-0.010.030.46-0.270.250.85-0.090.090.1
Net Income
-0.08-1.02-1.3-2.32-0.170.511.21-0.170.120.09
Net Income Common
-0.08-1.02-1.3-2.32-0.170.511.21-0.170.120.09
Net Income Growth
------58.09%--31.15%-
Shares Outstanding (Basic)
8775543333
Shares Outstanding (Diluted)
8775543333
Shares Change
5.25%5.78%24.29%10.85%14.14%36.97%4.58%-1.88%-0.75%4.14%
EPS (Basic)
-0.01-0.14-0.19-0.42-0.030.120.40-0.060.040.03
EPS (Diluted)
-0.01-0.14-0.19-0.42-0.030.120.38-0.060.040.03
EPS Growth
------68.42%--33.33%-
Free Cash Flow Per Share
-0.22-0.38-0.10-0.39-3.34-0.890.08-0.410.170.02
Gross Margin
45.00%44.70%49.10%47.30%50.10%56.80%61.10%58.60%50.90%56.70%
Operating Margin
1.30%-9.00%-7.00%-13.20%-2.30%9.30%20.70%-2.70%-0.30%4.50%
Profit Margin
-0.40%-6.70%-9.40%-21.10%-1.60%5.30%11.90%-2.20%2.00%1.70%
Free Cash Flow Margin
-8.50%-17.70%-5.20%-19.60%-158.60%-39.60%2.40%-16.20%8.30%1.30%
Effective Tax Rate
-13.26%0.98%-2.22%-24.82%61.65%32.95%41.21%34.56%42.81%53.42%
EBITDA
2.391.321-0.340.471.562.590.190.620.59
EBITDA Margin
12.40%8.60%7.30%-3.10%4.50%16.40%25.30%2.50%10.40%11.00%
Depreciation & Amortization
2.462.352.271.520.90.80.530.450.420.4
EBIT
-0.07-1.03-1.27-1.86-0.440.762.06-0.260.210.19
EBIT Margin
-0.40%-6.70%-9.20%-16.90%-4.20%7.90%20.20%-3.40%3.40%3.60%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).